Research Blends
GLOW
GLOW groups GHK-Cu, BPC-157 and a TB-500-listed component, bringing together separate lines of matrix-remodeling and tissue-signaling research.
$144USD / vial · 70 mg
Research only Research blend
Selank + Semax
Catalog size
$96
USD per vial · 10 mgCatalog price
Research onlySelank + Semax pairs two distinct synthetic peptides studied in neural signaling, with component-level findings that do not establish effects of the finished combination.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
No reservation or purchase is made by adding a material.
View documentation status ← Back to collection- Listed components
- Selank 5 mg + Semax 5 mg
- Format
- Awaiting confirmation
- Batch reports
- Check this size in the COA library
- Availability
- Confirmed during review
Catalog quantities are not assay results.
In the literature
The components. The research context.
Tuftsin-derived and ACTH-fragment-derived peptide research blend
Understanding the formulation
Selank and Semax are separate peptide designs rather than two names for the same molecule. Selank derives from the immune-related peptide tuftsin; Semax derives from an ACTH fragment. Their catalog combination lists equal component quantities. Shared discussion in neuropeptide research does not mean that they have the same targets, distribution or evidence base.
- Research class
- Tuftsin-derived and ACTH-fragment-derived peptide research blend
- Catalog search names
- Selank / Semax
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Why these components are studied
Selank research includes GABA-associated signaling and context-dependent gene expression. Semax experiments examine neurotrophin-related responses, including BDNF and its receptor system in animal tissues. A change in messenger RNA or protein expression may help identify a pathway, but cannot alone establish improved cognition, reduced anxiety or protection from neurological disease.
Documented lines of inquiry
Research areas
- 01
GABA-associated gene expression
Rat experiments examined changes in transcripts linked to GABA signaling. Such findings are mechanistic observations and should not be treated as proof of a direct receptor interaction in people. [1]
- 02
Neurotrophin signaling
Semax studies measured BDNF-related signaling in rat tissue. These experiments concern the isolated peptide and do not test whether Selank changes its response. [2]
- 03
Experimental neural injury
Animal cerebral-ischemia work investigated neurotrophin-related gene expression. It provides a model for pathway research, not evidence that this catalog blend prevents or treats human stroke. [3]
Study topics describe the cited models, not established benefits of this catalog material.
Reading the evidenceWhat the studies
Component evidence · finished blend untested in cited studies
What the studies
can tell us.
Component evidence · finished blend untested in cited studiesThe references selected for the combination are component-level animal and mechanistic studies. Individual peptide profiles also explain the scope of any additional human literature. No cited paper establishes a benefit, interaction or optimal ratio for the finished Selank + Semax formulation.
What remains uncertain
Brain-region specificity, species, timing and experimental stress can change neural readouts. Gene-expression differences may not translate into meaningful behavior or durable outcomes. Finished-mixture identity, stability and analytical recovery require their own documentation; they cannot be inferred from separate peptide publications.
Read the source
Selected literature
These papers concern individual components or related molecules. They do not validate this finished blend.
- 01PubMed
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission (opens a new tab)
Rat cortex transcription study; GABA-system modulation is an interpretation, not direct receptor-binding proof.
- 02PubMed
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus (opens a new tab)
Rat hippocampal signaling and behavior; not a human cognition trial.
- 03PubMed
Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia (opens a new tab)
Rat cerebral-ischemia transcription experiment; final publication 2010, online 2009.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Before you begin
The details behind
the material.
Specifications and storage
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
Research use only
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAContinue exploring.
All materialsOther research blends in the collection.
View details
Research Blends
KLOW
KLOW lists GHK-Cu, BPC-157, TB-500 and KPV, connecting component studies of skin-matrix remodeling, cell migration and intestinal inflammatory signaling.
$129USD / vial · 80 mg
Research only
Research Blends
Wolverine
Wolverine pairs BPC-157 with a TB-500-listed component, connecting preclinical tendon and gastrointestinal research with thymosin-related identity questions. The exact TB-500 sequence still requires confirmation.
$65USD / vial · 10 mg
Research only